Kirkland Signature Aller Fex Allergy Tablets Recalled for Failed Impurities Specifications
L. Perrigo Company recalls Kirkland Signature Aller Fex allergy tablets nationwide due to certain lots failing impurities and degradation quality specifications. Consumers with affected lots should contact their healthcare provider.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or adverse events. The hazard—failed impurities and degradation specifications—represents a quality control issue without demonstrated patient harm, consistent with a precautionary recall classification.
Plain-English summary
L. Perrigo Company is recalling Kirkland Signature Aller Fex (Fexofenadine Hydrochloride) 180 mg tablets because specific batches failed to meet FDA impurities and degradation specifications. The affected product includes 180-count cartons distributed nationwide.
Approximately 360,184 units have been distributed throughout the United States. Consumers should check their tablets against the affected lot numbers provided in the recall notice, which include lots with expiration dates ranging from November 2023 through April 2024.
If you have used this product, consult your healthcare provider if you have any concerns. Do not use affected lot numbers. Return the medication to your pharmacy or follow FDA disposal guidance.
The recalled product
- Product
- KIRKLAND SIGNATURE ALLER FEX (FEXOFENADINE HYDROCHLORIDE)
- Brand
- KIRKLAND SIGNATURE ALLER FEX
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Antihistamine
- Affected units
- 360,184
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 2DV1487
- 2DV1870
- 2DV1871
- 2DV1873
- 2EV1676
- 2GV2132
- 2HV2679
- Exp. date 12/23
- 2DV2000
- exp. date 11/23
- 2LV1573
- 2MV1314
- Exp. date 04/24
- 2FV1764
- 2FV1765 2FV1766
- 2GV1579
- 2GV1937
- 2GV1941
- 2GV1942
- 2GV2157
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by L. Perrigo Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · chemical degradation
See all →- SevereMaquet Sevoflurane vaporizer filling recalled due to potential hydrogen fluoride exposure
FDA (Devices) · 2022-01-19
- LowAidarex Recalls Enalapril Maleate Due to Out-of-Specification Degradation Product
FDA (Drugs) · 2018-08-01
- HighBest Sanitizers Recalls Acecide-C High Level Disinfectant Due to Acid Degradation
FDA (Devices) · 2016-09-14